Of the eight metabotropic glutamate (mGlu) receptor subtypes, only mGlu 7 is expressed presynaptically at the Schaffer collateral (SC)-CA1 synapse in the hippocampus in adult animals. Coupled with the inhibitory effects of Group III mGlu receptor agonists on transmission at this synapse, mGlu 7 is thought to be the predominant autoreceptor responsible for regulating glutamate release at SC terminals. However, the lack of mGlu 7 -selective pharmacological tools has hampered direct testing of this hypothesis. We used a novel, selective mGlu 7 -negative allosteric modulator (NAM), ADX71743, and a newly described Group III mGlu receptor agonist, LSP4-2022, to elucidate the role of mGlu 7 in modulating transmission in hippocampal area CA1 in adult C57BL/6J male mice. Interestingly, although mGlu 7 agonists inhibit SC-CA1 EPSPs, we found no evidence for activation of mGlu 7 by stimulation of SC-CA1 afferents. However, LSP4-2022 also reduced evoked monosynaptic IPSCs in CA1 pyramidal cells and, in contrast to its effect on SC-CA1 EPSPs, ADX71743 reversed the ability of high-frequency stimulation of SC afferents to reduce IPSC amplitudes. Furthermore, blockade of mGlu 7 prevented induction of LTP at the SC-CA1 synapse and activation of mGlu 7 potentiated submaximal LTP. Together, these data suggest that mGlu 7 serves as a heteroreceptor at inhibitory synapses in area CA1 and that the predominant effect of activation of mGlu 7 by stimulation of glutamatergic afferents is disinhibition, rather than reduced excitatory transmission. Furthermore, this mGlu 7 -mediated disinhibition is required for induction of LTP at the SC-CA1 synapse, suggesting that mGlu 7 could serve as a novel therapeutic target for treatment of cognitive disorders.
Introduction
Glutamate and GABA are the main excitatory and inhibitory neurotransmitters in the CNS. They act on two classes of receptors: fast-conduction ion channels and neuromodulatory 7 transmembrane receptors (7TMRs). For glutamate, these 7TMRs are termed metabotropic glutamate (mGlu) receptors and consist of eight members divided into three groups. Group I (mGlu 1 and mGlu 5 ), primarily mediate postsynaptic excitation. Group II (mGlu 2 and mGlu 3 ) are expressed presynaptically, postsynaptically, and on glial cells. Group III mGlu receptors include mGlu 4 , mGlu 6 , mGlu 7 , and mGlu 8 , which, with the exception of retinal mGlu 6 , are primarily expressed presynaptically and regulate neurotransmitter release (for review, see Niswender and Conn, 2010) . Among the Group III mGlu receptors, mGlu 7 has the lowest affinity for glutamate and is expressed on glutamatergic and GABAergic terminals (Bradley et al., 1996; Dalezios et al., 2002; Summa et al., 2013) . mGlu 7 is also widely expressed throughout the brain and is the most highly conserved of all the mGlu receptors, suggesting that its function is evolutionarily important (Bradley et al., 1996; Flor et al., 1997; Kinoshita et al., 1998) . mGlu 7 appears to be the only Group III mGlu present at the SC-CA1 synapse in the hippocampus in adult animals (Baskys and Malenka, 1991; Kosinski et al., 1999; Ayala et al., 2008) where it is localized presynaptically in the cleft of glutamatergic SC terminals (Shigemoto et al., 1996) and perfectly poised to serve as an autoreceptor activated by synaptically released glutamate to inhibit neurotransmission. Consistent with this observation, agonists that activate mGlu 7 inhibit transmission at the SC-CA1 synapse (Baskys and Malenka, 1991; Gereau and Conn, 1995; Ayala et al., 2008; Jalan-Sakrikar et al., 2014) . Although activation of mGlu 7 can reduce SC-CA1 transmission, previous studies have failed to provide clear evidence that mGlu 7 serves as an autore-ceptor that can be activated by glutamate released from SC terminals (Losonczy et al., 2003) . This has largely been due to a lack of selective mGlu 7 antagonists and reliance on the nonselective Group III orthosteric agonist, L-AP4 (Rosemond et al., 2004) . Recently, two novel compounds have been developed that now allow for more focused studies regarding mGlu 7 . Although also a highly potent mGlu 4 agonist, the compound LSP4-2022 is an agonist that is the most potent orthosteric activator of mGlu 7 reported to date (Goudet et al., 2012) . Additionally, the novel negative allosteric modulator (NAM), ADX71743, is a highly selective mGlu 7 antagonist with both in vitro and in vivo efficacy (Kalinichev et al., 2013) . Using these new tools, we provide evidence that stimulation of glutamatergic SC afferents does not activate mGlu 7 on presynaptic glutamatergic terminals but predominantly activates mGlu 7 heteroceptors to reduce GABA release from inhibitory synapses. Furthermore, mGlu 7 -dependent disinhibition is required for induction of LTP by high-frequency stimulation at this synapse. These findings challenge the prevailing view that mGlu 7 is an autoreceptor at SC terminals and suggest that activation of mGlu 7 by glutamatergic afferents may increase overall excitatory drive by reducing synaptic inhibition and enhancing LTP. These data add to an emerging interest in mGlu 7 as a novel therapeutic target for enhancing cognition.
Materials and Methods

Drugs
(Ϫ)Bicuculline methobromide, D-AP5, and LY341495 were purchased from Abcam Biochemicals. CNQX was purchased from R&D Systems. LSP4-2022 was synthesized in-house according to previously published methodology (Selvam et al., 2010) . (ϩ)-6-(2,4-Dimethylphenyl)-2-ethyl-6,7-dihydrobenzo [d] oxazol-4(5H)-one (ADX71743) was synthesized in-house according to the methods below. All drugs used for electrophysiology experiments were diluted in aCSF.
Chemical synthesis
All NMR spectra were recorded on a 400 MHz FT-NMR DRX-400 FT-NMR spectrometer or 500 MHz Bruker DRX-500 FT-NMR spectrometer.
1 H chemical shifts are reported in ␦ values in ppm downfield with the deuterated solvent as the internal standard. Data are reported as follows: chemical shift, multiplicity (s ϭ singlet, d ϭ doublet, t ϭ triplet, q ϭ quartet, br ϭ broad, m ϭ multiplet), integration, coupling constant (Hz). Low-resolution mass spectra were obtained on an Agilent 1200 series 6130 mass spectrometer with electrospray ionization. Highresolution mass spectra were recorded on a Waters Q-TOF API-US plus Acquity system with electrospray ionization. Analytical thin-layer chromatography was performed on EM Reagent 0.25 mm silica gel 60-F plates. Analytical HPLC was performed on an Agilent 1200 series with UV detection at 215 and 254 nm along with ELSD detection. LC/MS: (Phenomenex C18, 2.1 ϫ 30 mm, 1.5 min gradient, 7% [0.1% TFA/ CH3CN]: 93% [0.1% TFA/H 2 O] to 95% [0.1% TFA/CH3CN]). Preparative purification was performed on a custom HP1100 purification system (reference 16) with collection triggered by mass detection. Solvents for extraction, washing, and chromatography were HPLC grade. All reagents were purchased from Aldrich Chemical and were used without purification. (2,4-Dimethylphenyl)cyclohexane-1,3-dione (2) (reference: WO 2011/ 062964 A1) . To a suspension of 2,4-dimethylbenzaldehyde, 90% technical grade (1) (5.96 g, 40.0 mmol, 1.0 Eq) in acetone (6.0 ml) and H 2 O (8 ml) was added a 1% aqueous solution of NaOH (5 ml) dropwise. The reaction was heated to 70°C. After 4 h at 70°C, the reaction was cooled to room temperature and poured into H 2 O (100 ml). The mixture was extracted with CHCl 3 (3 ϫ 50 ml), and the collected organic layers were concentrated.
5-
To a solution of NaOMe (0.5 M in MeOH, 84 ml, 1.05 Eq) in MeOH (75 ml) was added diethyl malonate (6.2 ml, 40.0 mmol, 1.0 Eq), dropwise to maintain temperature between 15°C and 20°C. The previously isolated residue in MeOH (5 ml) was then added to the reaction at 60°C. The reaction was refluxed for 12 h. To the reaction was added a solution of NaOH (17.6 g) in H 2 O (70 ml). The reaction was heated to reflux for an additional hour. To the reaction was added concentrated HCl (15 ml) dropwise. After removing the reaction from the heat, EtOAc (200 ml) was added, and the organic layer was separated, washed with H 2 O (2 ϫ 80 ml), Brine (50 ml), and dried (MgSO 4 ). The mixture was filtered and the solvent removed under reduced pressure. The material was taken forward without further purification.
LCMS: RT ϭ 0.873 min, Ͼ92% @ 215 nM, m/z ϭ 217.0 [M ϩ H]ϩ. (reference: WO 2011/062964 A1) . To a solution of 5-(2,4-dimethylphenyl)cyclohexane-1,3-dione (2) (40.0 mmol, 1.0 Eq) in DCM (100 ml) at 0°C was added propionyl chloride (3.85 ml, 44.0 mmol, 1.1 Eq), followed by Et 3 N (6.7 ml, 48.0 mmol, 1.2 Eq). After 15 min, the cold bath was removed. Following 3 h at room temperature, the reaction was evaporated to dryness. The brown residue was redissolved in acetonitrile (50 ml), and acetone cyanohydrin (1 ml) and Et 3 N (1 ml) were added. After 18 h at room temperature, the reaction was concentrated and the residue was purified by reverse-phase HPLC (30%-90% acetonitrile: H 2 O w/ 0.1% TFA) to afford 3 (15%-20% over 3 steps).
5-(2,4-Dimethylphenyl)-2-propionylcyclohexane-1,3-dione (3)
LCMS: RT ϭ 1.211 min, Ͼ98% @ 215 and 254 nM, m/z ϭ 272. propylidene) cyclohexane-1,3-dione (4) . To a solution of 5-(2,4-dimethylphenyl)-2-propionylcyclohexane-1,3-dione (3) (210 mg, 0.77 mmol, 1.0 Eq) in EtOH (8 ml) at room temperature was added O-ethylhydroxylamine ⅐ HCl (79 mg, 0.81 mmol, 1.05 Eq), followed by NaOAc (70 mg, 0.85 mmol, 1.1 Eq). The heterogeneous yellow reaction was stirred for 16 h at room temperature. After the solvent was removed under vacuo, the residue was redissolved in DCM:H 2 O (100 ml, 1:1) and the organic layer was separated using a hydrophobic phase separator. After the solvent was removed, the material was taken on without further purification.
LCMS: RT ϭ 1.269 min, Ͼ98% @ 215 and 254 nM, m/z ϭ 315.8 [M ϩ H]ϩ. (2, . A solution of 5-(2,4-dimethylphenyl)-2-(1-(ethoxyamino)propylidene)cyclohexane-1,3-dione (4) (0.77 mmol, 1.0 Eq) in EtOH (50 ml) was heated to reflux. After 24 h at reflux, the reaction was concentrated and the residue was purified by reverse-phase HPLC (20%-75% acetonitrile: H 2 O w/ 0.1% TFA) to afford 5 (96.4 mg, 47% over 2 steps).
6-
LCMS 190.4, 166.4, 163.3, 137.0, 136.8, 135.2, 134.1, 131.8, 127.2, 125.4, 44.7, 36.7, 29.3, 21.7, 20.9, 19.3, 10.9 .
Animals
All of the animals used in the present studies were group housed with food and water available ad libitum. Animals were kept under a 12 h light/dark cycle with lights on from 6:00 A.M.to 6:00 P.M. and were tested during the light phase. All of the experimental procedures were approved by the Vanderbilt University Animal Care and Use committee and followed the guidelines set forth by the Guide for the Care and Use of Laboratory Animals.
Extracellular field potential recordings
The 6-week-old male C57BL/6J mice (The Jackson Laboratory) were anesthetized with isofluorane, and the brains were removed and submerged in ice-cold cutting solution containing the following (in mM): 230 sucrose, 2.5 KCl, 8 MgSO 4 , 0.5 CaCl 2 , 1.25 NaH 2 PO 4 , 10 D-glucose, 26 NaHCO 3 . Coronal slices containing the hippocampus were cut at 400 m using a Compresstome (Precisionary Instruments). Slices were transferred to a holding chamber containing NMDG-HEPES recovery solution (in mM) as follows: 93 NMDG, 2.5 KCl, 1.2 NaH 2 PO 4 , 30 NaHCO 3 , 20 HEPES, 25 D-glucose, 5 sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 10 MgSO 4 , 0.5 CaCl 2 , pH 7.3, 305 mOsm, for 15 min at 32°C. Slices were then transferred to a room temperature holding chamber for at least 1 h containing aCSF (in mM) as follows: 126 NaCl, 1.25 NaH 2 PO 4 , 2.5 KCl, 10 D-glucose, 26 NaHCO 3 , 2 CaCl 2 , 1 MgSO 4 , supplemented with 600 M sodium ascorbate for slice viability. All buffers were continuously bubbled with 95% O 2 /5% CO 2 . Subsequently, slices were transferred to a 32°C submersion recording chamber where they were perfused with aCSF at a rate of 2 ml/min. Borosilicate glass electrodes were pulled using a Flaming/Brown micropipette puller (Sutter Instruments) and had a resistance of 3-5 M⍀ when filled with aCSF. Paired-pulse field EPSPs (fEPSPs) were recorded by from the stratum radiatum of CA1 and evoked by electrical stimulation (100 s duration, every 20 s) delivered through a concentric bipolar stimulating electrode placed near the CA3-CA1 border. Input-output curves were generated for each slice, and the stimulation intensity was adjusted to 50%-60% of the maximum response. The effect of mGlu 7 compounds on basal synaptic transmission was monitored by applying paired-pulse stimulation with an interpulse interval of 20 ms at 0.05 Hz. After a 10 min baseline recording, 30 M LSP4-2022 was bath-applied for 10 min and then washed out for 15 min. Alternatively, after a 5 min baseline, slices were pretreated with 3 M ADX71743 for 5 min before coapplication of 3 M ADX71743 and 30 M LSP4-2022 for 10 min, followed by a 15 min washout period. For frequency-dependent fEPSP experiments, two different stimulation paradigms were used. For both paradigms, slices were perfused with bicuculline for the entire experiment and a cut was made at the CA3-CA1 border to prevent recurrent burst firing. A train of 5 fEPSPs was evoked by stimulating 5 times at a frequency of 10 Hz with a 30 s intertrain interval (ITI). Baseline values were recorded for 10 min before the addition of ADX71743 for 10 min. Additionally, a second stimulation paradigm was also used in which a single pulse was delivered 550 ms before 10 pulses delivered at 100 Hz followed by a second test pulse 550 ms later. Baseline values were recorded for 10 min before addition of ADX71743 for 10 min. The slopes from two sequential sweeps were averaged. All slopes calculated were normalized to the average slope calculated during the predrug period ( percentage of baseline).
Saturated LTP was induced by applying either two or three trains of 100 Hz stimulation (1 s duration, 20 s ITI) directly following a 10 min baseline. Threshold LTP was induced by applying one train of 100 Hz stimulation (1 s). LTP in the presence of bicuculline was performed in a modified aCSF (in mM) as follows: 126 NaCl, 1.25 NaH 2 PO 4 , 2.5 KCl, 10 D-glucose, 26 NaHCO 3 , 4 CaCl 2 , 4 MgSO 4 , and 20 M bicuculline. A surgical cut was made between CA3 and CA1 regions to prevent epileptiform activity. Slices were perfused with 20 M bicuculline, the fEPSP slope was allowed to stabilize before an input-output curve was generated, and the stimulation intensity was adjusted to 50% of the maximum fEPSP slope generated in bicuculline. For a subset of LTP experiments performed in the presence of bicuculline, an input-output curve was first generated in normal aCSF. Slices were then perfused with 20 M bicuculline, and the stimulation intensity was adjusted so that the fEPSP slope used at baseline in bicuculline was the same as the 50% slope value calculated from the input-output curve in normal aCSF. Sampled data were analyzed offline using Clampfit 10.2 (Molecular Devices). The slopes from three sequential sweeps were averaged. All slopes calculated were normalized to the average slope calculated during the predrug period (percentage of baseline). Data were digitized using a Multiclamp 700B, Digidata 1322A, and pClamp 10 software (Molecular Devices). All drugs were diluted in aCSF and bath applied.
Whole-cell patch-clamp recordings
Whole-cell patch-clamp recordings were performed using coronal slices prepared from either 6-week-old male C57BL/6J mice (The Jackson Laboratory) or 6-week-old male mice expressing channelrhodopin 2 (B6;129S-Gt(ROSA)26Sor tm32(CAG-COP4*H134R/EYFP)Hze /J; ChR2) in parvalbumin (PV)-expressing interneurons (B6;129P2-Pvalb tm1(cre)Arbr /J:PV). The PV-ChR2 mice were generated by crossing mice expressing cre recombinase under the control of a PV promoter with mice expressing conditional ChR2. All animals were anesthetized using a 0.2 ml intraperitoneal injection of ketamine/xylazine (20 mg/2 mg/ml) and then transcardially perfused with ice-cold cutting solution. Mice were then decapitated, and the brains were removed and submerged in ice-cold cutting solution as described above. Coronal slices containing the hippocampus were cut at 300 m using a Compresstome (Precisionary Instruments). Slices were then transferred to a holding chamber containing a modified NMDG-HEPES recovery solution (in mM) as follows: 93 NMDG, 2.5 KCl, 1.2 NaH 2 PO 4 , 30 NaHCO 3 , 20 HEPES, 25 D-glucose, 5 sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 10 MgSO 4 , 0.5 CaCl 2 , 12 N-acetyl-L-cysteine, pH 7.3, 305 mOsm, and recovered as described above. After the initial recovery period, slices were transferred to a holding chamber containing modified aCSF for at least 30 min (in mM) as follows: 126 NaCl, 1.25 NaH 2 PO 4 , 2.5 KCl, 10 D-glucose, 26 NaHCO 3 , 2 CaCl 2 , 1 MgSO 4 , supplemented with 600 M sodium ascorbate for slice viability. Slices were perfused with 2 ml/min aCSF at 32°C in a submersion recording chamber. A cut was made at CA3 in all slices to prevent recurrent burst firing. Neurons were visualized with a 40ϫ water-immersion lens with Hoffman modulation contrast optics coupled with an Olympus BX50WI upright microscope (Olympus). Borosilicate glass pipette electrodes were pulled as described above and had a resistance of 5-7 M⍀ when filled with an intracellular solution containing (in mM) as follows: 120 CsMeSO 3 , 1 CaCl 2 , 1 MgSO 4 , 11 CsCl, to 7.3 with CsOH; 290 mOsm. Whole-cell recordings were made from visualized CA1 pyramidal neurons. IPSCs were evoked by placing a concentric bipolar stimulating electrode near the CA3-CA1 border. After formation of a whole-cell configuration, the membrane potential was voltage-clamped at 0 mV by injection of current. Evoked IPSCs (eIPSCs) were recorded by applying paired-pulse stimulations 200 ms apart with a 20 s intersweep interval for monosynaptic and polysynaptic experiments. Input-output curves were generated for each cell, and the stimulation intensity was adjusted to 50%-70% of the maximum response. For monosynaptic eIPSC experiments and frequency-dependent IPSC experiments, slices were continuously perfused with 20 M CNQX and 50 M D-AP5 to block glutamatergic transmission. For frequency-dependent IPSC experiments, two different stimulation paradigms were used that were similar to those used in the frequency-dependent fEPSP experiments. A train of 5 IPSCs was evoked by stimulating 5 times at a frequency of 5 Hz with a 30 s ITI. Baseline values were recorded for 5 min before the addition of either LY341495 or ADX71743 for 10 min. Additionally, a second stimulation paradigm was also used in which a single pulse was delivered 550 ms before 10 pulses delivered at 100 Hz followed by a second test pulse 550 ms later. Baseline values were recorded for 5 min before addition of either LY341495 or ADX71743 for 10 min. The amplitudes from two sequential sweeps were averaged. All amplitudes calculated were normalized to the average amplitude calculated during the predrug period (percentage of baseline).
Optogenetically induced IPSCs (oIPSCs) were generated using a CoolLED pE-100 illumination system (CoolLED) connected to an Olympus microscope (Olympus). A 473 nm blue light beam was applied to the slice through the 40ϫ water-immersion objective as described previously (Pancani et al., 2014) . Paired oIPSCs were generated by applying paired light pulse stimulation (1 ms in duration each spaced 700 ms apart). This stimulation paradigm was repeated every 20 s for the duration of the experiment. Input-output curves were generated for each cell, and the light intensity was adjusted to 50%-70% of the maximum response. The amplitudes from three sequential sweeps were averaged into minute bins. All data were digitized using a Multiclamp 700B, Digidata 1322A, and pClamp 10 software (Molecular Devices). All drugs were diluted in aCSF and bath applied.
Statistical analysis
All data shown represent mean Ϯ SEM for at least three replicates. Statistical significance between groups was determined using unpaired or paired Student's t tests, one-way ANOVA (with Bonferroni's post-test), or two-way ANOVA (with Bonferroni's post-test) as specified in each figure legend.
Results
Stimulation of SC afferents does not induce feedback inhibition of transmission by activation of mGlu 7
If mGlu 7 functions as a classical autoreceptor to provide feedback inhibition of transmission at the SC-CA1 synapse, stimulation of SC afferents should induce an activity-dependent decrease in EPSP amplitude that can be reversed by mGlu 7 antagonists. This phenomenon has been observed for Group II mGlu receptors in the dentate gyrus, where an mGlu 2/3 antagonist inhibits an activity-dependent reduction in EPSC amplitude that is seen with stimulation of glutamatergic afferents (Doherty et al., 2004) . We found that the new highly selective mGlu 7 NAM, ADX71743 (3 M) (Kalinichev et al., 2013) , inhibits the ability of the recently described mGlu 7 agonist, LSP4-2022 (30 M) (Goudet et al., 2012) , to reduce transmission at the SC-CA1 synapse, confirming a role for mGlu 7 in reducing transmission with exogenous agonists (LSP4-2022 alone: 82.3 Ϯ 1.7% of baseline, ADX71743 ϩ LSP4-2022: 102.6 Ϯ 2.2% of baseline, n ϭ 4 slices) ( Fig. 1 A, B) . Although LSP4-2022 activates mGlu 4 , mGlu 7 , and mGlu 8 , this compound is the most potent mGlu 7 agonist to date and is the first mGlu 7 agonist that provides selectivity for mGlu 7 relative to mGlu 8 (Goudet et al., 2012) . Because mGlu 4 is not present or active at SC-CA1 synapses (Ayala et al., 2008) , LSP4-2022 provides an excellent tool to probe mGlu 7 function at SC-CA1 synapses in adult animals. The concentrations of ADX71743 and LSP4-2022 used in these studies were based on extensive studies evaluating the potencies of these compounds mGlu 7 -expressing cell lines. These studies were consistent with published results and an established IC 50 of 300 nM for ADX71743 (the IC 50 determined using in-house cell lines is 300 Ϯ 57 nM; data not shown) and an EC 50 of 10 M for LSP4-2022 at mGlu 7 , respectively (data not shown).
To test the hypothesis that mGlu 7 serves as an autoreceptor at the SC-CA1 synapse, we measured fEPSPs in 6-week-old C57BL/6J male mice in response to repeated, low-frequency stimulation in the presence of bicuculline to isolate a pure glutamatergic component. We chose to study this phenomenon in adult animals because of the presence of a developmental switch that occurs between the expression of mGlu 8 and mGlu 7 at SC-CA1 synapses, where mGlu 8 is the only Group III mGlu receptor expressed in neonatal animals and mGlu 7 is the only one present in adult animals (Ayala et al., 2008) . Initially, we applied 10 Hz stimulation for 0.5 s to induce a series of 5 fEPSPs. In contrast to previous studies of Group II mGlu receptors at the mossy fiberhilar interneuron synapse (Doherty et al., 2004) , there was a slight increase, rather than decrease, in fEPSP slope relative to the initial fEPSP with each subsequent stimulation in the train (Fig. 1C,D) . To determine whether fEPSP slope was influenced by activation of mGlu 7 during this train, 3 M ADX71743 was bath applied after a 10 min baseline recording. We have determined that this concentration of ADX71743 completely blocks effects of LSP4-2022 on fEPSP slope at this synapse ( Fig. 1 A, B) . Interestingly, ADX71743 had no significant effect on fEPSP slope for any of the five fEPSPs in the train (Fig.  1C ,D, black traces vs red traces). These results indicate that mGlu 7 does not function as a traditional autoreceptor to reduce presynaptic glutamate release using this low-frequency repeated stimulation paradigm.
The lack of effect of ADX71743 on fEPSP slope with lowfrequency stimulation, coupled with mGlu 7 's extremely low affinity for glutamate, raises the possibility that mGlu 7 is only activated with stronger, higher frequency activity that may be necessary to release sufficient glutamate into the SC-CA1 synapse to activate mGlu 7 . If so, rather than being activated under conditions of normal low-frequency activity, mGlu 7 could act as a brake to reduce glutamate release only under conditions of extremely high-frequency firing. To investigate this possibility, we used a stimulation paradigm that mimicked a classical highfrequency stimulation (HFS) paradigm used to induce LTP at the SC-CA1 synapse. For this high-frequency protocol, an initial fEPSP was generated 550 ms before a train of 10 pulses delivered at 100 Hz. At 550 ms after the last pulse of the train, a second fEPSP was generated as a test response. This paradigm was repeated every 30 s. We then measured the ratio between the slope of the initial fEPSP (stimulation 1) and the slope of the test response fEPSP (stimulation 2) (ratio calculated as fEPSP slope 2/fEPSP slope 1). We found no significant change in the ratio between the two fEPSP slopes in response to ADX71743 treatment ( Fig. 1 E, F , black traces vs red traces). These results suggest that mGlu 7 does not act as an autoreceptor at SC-CA1 synapses to decrease glutamate release, even with this high-frequency stimulation protocol.
mGlu 7 decreases monosynaptic GABAergic IPSCs
In addition to its localization on presynaptic terminals of excitatory synapses onto CA1 pyramidal cells, mGlu 7 is also localized on presynaptic terminals of excitatory synapses onto inhibitory interneurons and on inhibitory GABAergic synapses onto pyramidal cells. If stimulation of SC afferents activates mGlu 7 at either of these locations, this could reduce inhibitory transmission in CA1 pyramidal cells. Because of the lack of a clear role for mGlu 7 as a classical autoreceptor at SC-CA1 pyramidal cell synapses, we evaluated the potential role of mGlu 7 in regulating inhibitory transmission in area CA1. Whole-cell patch-clamp techniques were used to record eIPSCs in visually identified CA1 pyramidal cells from acute brain slices from 6-week-old C57BL/6J male mice. Studies of the effect of LSP4-2022 on paired-pulse IPSCs revealed that application of 30 M LSP4-2022 caused a significant decrease in IPSC amplitude (80.2 Ϯ 2.4% of baseline, n ϭ 7 cells) ( Fig.  2 A, B,D) with a concomitant increase in the paired pulse ratio (PPR, 0.69 Ϯ 0.04 in baseline vs 0.87 Ϯ 0.06 in LSP4-2022) (Fig. 2F ) . The effect of LSP4-2022 on eIPSC amplitude washed out from most cells (5 of 7 cells) after 15 min of perfusion with normal aCSF (Fig. 2E) . Additionally, LSP4-2022 had no effect on IPSC kinetic parameters, including the rise time or decay time of IPSCs (rise time: 9.23 Ϯ 0.7 ms at baseline vs 9.32 Ϯ 0.7 ms during LSP4-2022 addition; decay time: 129.4 Ϯ 6.6 at baseline vs 116.9 Ϯ 7.9 ms during LSP4-2022 addition) (Fig. 2C,G,H ) . Consistent with the hypothesis that the effects of LSP4-2022 are mediated by mGlu 7 , these effects were completely blocked by the mGlu 7 NAM, ADX71743 (data not shown).
These results suggest that activation of mGlu 7 decreases GABAergic synaptic transmission in CA1 pyramidal cells and that this is likely mediated by a presynaptic mechanism. However, these studies do not provide insights as to whether mGlu 7 reduces inhibitory transmission by actions at excitatory synapses onto inhibitory interneurons or direct inhibition of GABA release at inhibitory synapses onto pyramidal cells. To determine whether mGlu 7 functions presynaptically on GABAergic terminals, we isolated monosynaptic IPSCs by incubating slices with a combination of CNQX and D-AP5, antagonists of AMPA receptor and NMDA receptors, respectively, to block glutamatergic transmission. This experimental paradigm allowed us to remove the contribution of any mGlu 7 expressed presynaptically on glutamatergic terminals synapsing onto interneurons and allowed us to isolate monosynaptic IPSCs to evaluate effects of mGlu 7 expressed on GABAergic interneurons. Slices were pretreated with a combination of 20 M CNQX and 50 M D-AP5 for several minutes until stable monosynaptic IPSCs were obtained. These IPSCs could be completely blocked by the application of 20 M bicuculline (data not shown). The 30 M LSP4-2022 was then perfused for 10 min onto the slice, which resulted in a significant decrease in IPSC amplitude (78.4 Ϯ 1.8% of baseline, n ϭ 7 cells) (Fig. 3 A, B,D) and also resulted in a significant increase in PPR (0.6 Ϯ 0.02 during baseline vs 0.7 Ϯ 0.02 in LSP4-2022) (Fig. 3F ) . The effect of LSP4-2022 on eIPSC amplitude washed out from most cells (5 of 7 cells) after 15 min of perfusion with normal aCSF (Fig. 3E) . The kinetic parameters of the IPSCs did not significantly change with application of LSP4-2022 (rise time: 7.9 Ϯ 1.2 ms at baseline vs 7.8 Ϯ 1.0 ms during LSP4-2022 addition; decay time: 111.6 Ϯ 10.2 ms at baseline vs 107.9 Ϯ 13.1 ms during LSP4-2022 addition) (Fig.  3C,G,H ) . These results support previous anatomical studies suggesting that mGlu 7 is expressed presynaptically on GABAergic terminals (Kinoshita et al., 1998), and demonstrate that LSP4-2022 can activate mGlu 7 and decrease GABA release from these cells.
The ability of LSP4-2022 to reduce eIPSC amplitude even when glutamatergic transmission is blocked strongly suggests that the primary location of mGlu 7 is directly on GABAergic terminals. However, although the previous experimental setup eliminates the contribution of mGlu 7 expressed in glutamatergic terminals, it does not prevent the effects of neuromodulators that may be released in response to electrical stimulation. To remove the contribution of neuromodulators, such as norepinephrine, acetylcholine, serotonin, BDNF and others, and to further isolate only mGlu 7 expressed on interneurons, we used mice that expressed channel rhodopsin 2 (ChR2) in parvalbumin (PV)-expressing interneurons, as PV interneurons represent the largest populations of interneurons in this area (Kawaguchi et al., 1987; Klausberger et al., 2005) . This allowed us to directly activate only interneurons without the coincident release of other neuromodulatory factors. Paired optically activated IPSCs (oIPSCs) were recorded from CA1 pyramidal cells and evoked using 473 nm light. After a 10 min baseline period, 30 M LSP4-2022 was perfused for an additional 10 min, which resulted in a significant decrease in oIPSC amplitude (76 Ϯ 65.1% of baseline, n ϭ 6 cells) (Fig. 4 A, B,D) and also resulted in a significant increase in PPR (0.6 Ϯ 0.02 during baseline vs 0.73 Ϯ 0.03 in LSP4-2022) (Fig.  4F ) . The effect of LSP4-2022 on oIPSC amplitude washed out from most cells (4 of 6 cells) after 15 min of perfusion with . n ϭ 7 cells; df ϭ 6. G, H, Application of 30 M LSP4-2022 had no effect on the rise time (G) or decay time (H ) of polysynaptic eIPSCs (rise time: p ϭ 0.98, two-tailed Student's t test, n ϭ 7 cells, df ϭ 12; decay time: p ϭ 0.251, two-tailed Student's t test, n ϭ 7, df ϭ 12).
normal aCSF (Fig. 4E) . The kinetic parameters of the IPSCs did not significantly change with application of LSP4-2022 (rise time: 3.2 Ϯ 0.5 ms during baseline vs 3.0 Ϯ 0.6 ms in LSP4-2022; decay time: 205.4 Ϯ 26.6 ms during baseline vs 182.7 Ϯ 18.2 ms in LSP4-2022) (Fig. 4C,G,H ) . These results further support the hypothesis that mGlu 7 can decrease GABA release in a monosynaptic fashion, particularly without the contribution of other neuromodulators.
High-frequency stimulation of SC afferents induces an mGlu 7 -dependent decrease in monosynaptic GABAergic IPSCs
Our results and previous studies (Losonczy et al., 2003) suggest that mGlu 7 may not act as a traditional autoreceptor to decrease glutamate release in response to synaptic activation at glutamatergic synapses in area CA1. It is possible that a more prominent role of mGlu 7 in responding to activation of SC afferents is as a heteroceptor, where it could decrease GABA release in response to activation of SC afferents. If so, this could lead to a net increase, rather than decrease, in excitatory drive through area CA1. To assess the role of mGlu 7 heteroceptors in modulating responses to activation of SC afferents, we measured the effects of lowfrequency and high-frequency stimulation on monosynaptic IPSCs in CA1 pyramidal cells. Initially, we measured IPSCs evoked by low-frequency stimulation (5 Hz stimulation for 1 s).
Using this stimulation paradigm, we observed a decrease in IPSC amplitude with each subsequent stimulus (Fig. 5 A, B, black line) . To determine whether activation of mGlu 7 contributes to this activity-dependent depression of IPSCs, we established a baseline response for 5 min and then applied ADX71743 (3 M) for 10 min and measured the change in amplitude for each IPSC as a percentage of the first IPSC amplitude during the baseline period. ADX71743 did not induce a significant change in any of the IPSCs in the train (Fig. 5 A, B , black line vs red line), suggesting that mGlu 7 activation does not contribute to activity-dependent depression of IPSCs with low-frequency stimulation. We then used a high-frequency stimulation paradigm, similar to the one used to investigate the effect of mGlu 7 antagonists on fEPSPs. As in studies of excitatory transmission, an initial IPSC was generated 550 ms before a train of 10 pulses delivered at 100 Hz, repeated every 30 s. At 550 ms later, a second IPSC was generated as a test response (Fig. 5C ). Under baseline conditions, the test response elicited 550 ms after the 100 Hz train was smaller in amplitude than the first IPSC induced before 100 Hz stimulation. Interestingly, application of ADX71743 (3 M) reversed the ability of the stimulus train to reduce IPSC amplitude and increased the ratio between the amplitude of the second IPSC and the first IPSC (ratio calculated as IPSC amplitude 2/IPSC amplitude 1) (ratio ϭ 0.58 Ϯ 0.03 at baseline vs 0.65 Ϯ 0.02 during ADX71743 addition) (Fig. 5 D, E) . To confirm the effects of ADX71743, we repeated these experiments using the nonselective but wellcharacterized orthosteric mGlu receptor antagonist, LY341495, which has an IC 50 at mGlu 7 of ϳ1 M ( Kingston et al., 1998) . Consistent with the effects of ADX71743, 100 M LY341495 had no effect on IPSCs using the low-frequency (0.5 Hz) protocol (Fig. 5 F, G) . However, 100 M LY341495 had an effect that was similar to that of ADX71743 on responses to 100 Hz (Fig. 5 H, I ; ratio ϭ 0.59 Ϯ 0.03 at baseline vs 0.68 Ϯ 0.03 during LY341495 addition). To confirm that the effect on the ratio was drug-induced and not due to current run-down, we performed several experiments in which the stimulation protocol was run for 15 min with no drug addition, and observed no significant change in the ratio (data not shown). Collectively, these results suggest that mGlu 7 decreases GABA release in a frequency-dependent manner and that, under HFS conditions, mGlu 7 activation reduces GABA release. mGlu 7 activation is necessary for induction of LTP at SC-CA1 synapses in the hippocampus HFS at the SC-CA1 synapse results in an LTP that has previously been shown to be mediated by NMDA receptors (Morris et al., 1986) . Induction of NMDA receptor (NMDAR)-dependent LTP at the SC-CA1 pyramidal cell synapses requires coincident release of glutamate from presynaptic SC terminals and depolarization of CA1 pyramidal cells to allow release of voltage-dependent block of NMDARs by magnesium (Granger and Nicoll, 2014).
Activation of inhibitory interneurons in area CA1 by SC activation can oppose pyramidal cell depolarization required for induction of LTP, and GABA A receptor antagonists facilitate LTP induction (Debray et al., 1997) . Because mGlu 7 decreases GABA release under HFS conditions, we sought to determine whether this mechanism played a role in the induction of LTP. To probe this possibility, HFS was applied and fEPSPs were recorded in area CA1 of the hippocampus. A saturating form of LTP was induced by applying 2 trains of HFS (100 Hz, 1 s in duration, 20 s ITI). Consistent with previous studies (Harris and Teyler, 1984; Collingridge et al., 1988) , this resulted in a robust LTP assessed 1 h after HFS (141.9 Ϯ 7.1% of baseline). Pretreatment of slices with the mGlu 7 NAM, ADX71743 (3 M), for 20 min before HFS resulted in an almost complete blockade of LTP induction (100.6 Ϯ 1.4% of baseline) (Fig. 6 A, B) . As ADX71743 is a newly described mGlu 7 NAM, we performed the same experiment in the presence of 300 nM ADX71743, which is a concentration that should no longer fully block mGlu 7 in slices. Pretreatment with 300 nM ADX71743 for 20 min before HFS was no longer sufficient to block LTP (control: 143.2 Ϯ 6.4% of baseline, 300 nM ADX71743: 147.1 Ϯ 6.4% of baseline) (Fig. 6 A, B) . Furthermore, pretreatment with either 10 or 100 M LY341495, two concentrations well above the IC 50 at mGlu 7 , for 20 min before HFS stimulation resulted in a similar blockade of LTP (100.2 Ϯ 2.7% of baseline for 10 M LY341495, 106.9 Ϯ 5.8% of baseline for 100 M LY341495) (Fig. 6C,D) . Pretreatment with 100 nM LY341495, a concentration well below the IC 50 at mGlu 7 but one that blocks the Group II mGlu receptors, did not result in a significant blockade of LTP (134.6 Ϯ 19.6% of baseline) (Fig. 6C,D) . To determine whether there was an effect of either ADX71743 or LY341495 on any of the responses generated during the HFS, we measured the slopes of the fEPSPs generated during the first train of 100 Hz stimulation. We observed no significant change in the slope of the fEPSP generated after the first stimulation in the train with addition of either 3 M ADX71743 or 10 M LY341495, indicating that mGlu 7 is not active before the HFS (control: 100.0 Ϯ 14.8%, ADX71743: 114.7 Ϯ 29.6%, LY341495: 104.4 Ϯ 20.5% of control first fEPSP slope) (Fig. 6E-G) . We chose to investigate the 10 M LY341495 concentration because this was the lowest concentration sufficient to block LTP. Examining the fEPSP slopes at stimulus 20, 40, 60, 80, or 100 within the train, we observed a significant reduction in the fEPSP slopes at stimulus 20 and 40 compared with the slope of the first fEPSP with ADX71743 or LY341495 treatment, indicating that the responses decayed faster when mGlu 7 was blocked (stimulus 20: control: 18.7 Ϯ 2.3%, ADX71743: 9.7 Ϯ 2.5%, LY341495: 7.0 Ϯ 2.1% of first fEPSP slope, stimulus 40: control: 12.6 Ϯ 1.9%, ADX71743: 4.6 Ϯ 2.1%, LY341495: 1.8 Ϯ 1.6% of first fEPSP slope) (Fig. 6H ) . These results are consistent with our finding described above (Fig. 5 ) and indicate that mGlu 7 activation during the HFS, which leads to an increase in excitation of CA1 cells resulting from mGlu 7 -mediated disinhibition, is required for induction of LTP at SC-CA1 synapses.
To confirm that the mechanism by which mGlu 7 facilitates LTP is via disinhibition, we pretreated slices with 20 M bicuculline, a GABA A antagonist, to remove any contribution of GABAergic transmission to the fEPSPs. Application of 20 M bicuculline resulted in a significant increase in the fEPSP slope (217.8 Ϯ 10.9% vs baseline fEPSP slope; data not shown), which stabilized after 10 min of continuous bicuculline perfusion. After a stable fEPSP slope was obtained in the presence of 20 M bicuculline, LTP was induced either in the presence or absence of 20 min pretreatment with 3 M ADX71743. LTP was induced with the saturating LTP paradigm of two trains of HFS. Bicuculline alone produced a significantly greater level of LTP compared with normal ACSF conditions (159.2 Ϯ 2.4% for bicuculline vs 135.2 Ϯ 0.3% for normal ACSF) (Fig.  7 A, B) . The addition of a 20 min pretreatment with 3 M ADX71743 was no longer sufficient to block induction of LTP in the presence of bicuculline (153.1 Ϯ 3.4% of baseline) (Fig. 7 A, B) . To ensure that the increased level of LTP in the presence of bicuculline did not result in changes in local circuitry that could confound the lack of ADX71743 blockade, we modified the stimulation paradigm to achieve a similar magnitude of LTP induction in normal aCSF and in the presence of bicuculline. An input-output curve was first generated in normal aCSF to determine the 50% slope value. Slices were then perfused with 20 M bicuculline, and the stimulation intensity was reduced to generate fEPSPs with the same slope value calculated in normal aCSF. LTP was then generated using two trains of HFS. Under these conditions, we observed no significant difference in the level of LTP between normal aCSF and bicuculline (140.3 Ϯ 2.3% in bicuculline) ( Fig.  7C,D; small dashed line indicates level of LTP observed in normal aCSF). Additionally, pretreatment with ADX71743 was still not sufficient to block LTP (139.1 Ϯ 2.5%). As a modified version of aCSF was used in these experiments, we next confirmed that the form of LTP induced in the presence of bicuculline was still NMDA receptor-dependent; 20 M bicuculline was again bath applied until a stable fEPSP slope was obtained. Slices were then pretreated for 10 min with 50 M D-AP5, an NMDA receptor antagonist, before HFS. This resulted in a complete blockade of LTP induction (98.2 Ϯ 2.3% vs LTP induced in the presence of bicuculline alone; data not shown). Together, these data indicate that the mechanism by which mGlu 7 activation contributes to LTP induction is through a frequency-dependent reduction of GABAergic tone at SC-CA1 synapses. Additionally, the finding that the ability of ADX71743 to block LTP is completely abolished in the presence of bicuculline further suggests that disinhibition is the primary, if not only, mechanism by which mGlu 7 regulates LTP induction.
Agonism of mGlu 7 can potentiate LTP
To further investigate the role of mGlu 7 in induction of LTP at SC-CA1 synapses, we performed experiments using a submaximal HFS stimulation paradigm to induce a threshold level of LTP to determine whether agonism of mGlu 7 could potentiate this threshold level of LTP. Three different HFS paradigms were first used to identify saturating and threshold levels of LTP in our system. One train of HFS (100 Hz, 1 s) produced a moderate level of LTP (113.8 Ϯ 4.9% of baseline), whereas 2 trains of HFS (20 s (Fig. 8 A, B) . We next determined whether activation of mGlu 7 using LSP4-2022 could potentiate induction of LTP in response to a threshold stimulus. Pretreatment of slices with 30 M LSP4-2022 for 10 min before the threshold HFS (1 train of 100 Hz) resulted in a significant potentiation of the level of LTP measured after HFS (131.6 Ϯ 4.2% of baseline) (Fig. 8C,D) . As additional validation of an mGlu 7 -mediated effect, we performed the same experiment with a lower concentration of LSP4-2022 (3 M), which should no longer activate mGlu 7 (Goudet et al., 2012) . Pretreatment of slices with 3 M LSP4-2022 was no longer sufficient to potentiate LTP induced by one train of HFS (111.5 Ϯ 1.3% of baseline) (Fig. 8 E, F ) . Finally, to confirm that the mechanism by which LSP4-2022 potentiates LTP is via disinhibition, we again pretreated slices with 20 M bicuculline to remove any GABAergic contribution to the fEPSPs. We used the same experimental paradigm as used in Figure 7C , D to achieve a similar magnitude of LTP in the presence of bicuculline to that of control conditions. One train of HFS applied in the presence of bicuculline induced a similar magnitude of LTP to that induced in control conditions (114.6 Ϯ 1.5% of baseline) ( Fig. 8G,H; small dashed line indicates level of LTP observed in normal aCSF). Additionally, in the presence of bicuculline, 30 M LSP4-2022 was no longer sufficient to potentiate the level of LTP (114.7 Ϯ 1.8% of baseline) (Fig. 8G,H ) . These results are consistent with the hypothesis that activation of mGlu 7 can potentiate LTP at SC-CA1 synapses via a disinhibition of CA1 pyramidal cells (Fig. 9) . Moreover, when considered with the results from the mGlu 7 NAM experiments, our results suggest that activation of mGlu 7 is necessary for induction of LTP at this synapse.
Discussion
mGlu 7 is unique from other Group III mGlu receptors in that it has an extremely low affinity for glutamate, is present on both glutamatergic and GABAergic terminals, and is the only functional Group III receptor present at SC-CA1 synapses in the hippocampus (Bradley et al., 1996; Kosinski et al., 1999; Dalezios et al., 2002; Ayala et al., 2008; Summa et al., 2013) . Its role in regulating transmission in hippocampal area CA1 has been thought to be primarily through reduction of glutamatergic transmission, as mGlu 7 agonists reduce fEPSP slopes (Baskys and Malenka, 1991; Gereau and Conn, 1995; Ayala et al., 2008; Jalan-Sakrikar et al., 2014) . We and others, however, have not found a clear role for mGlu 7 in regulating endogenous glutamate release. In contrast to what has been seen for mGlu 2/3 in the dentate gyrus, we saw no activation of mGlu 7 in response to repeated SC afferent stimulations either at 5 Hz or at 100 Hz. These results suggest that mGlu 7 may not act as a traditional autoreceptor and does not decrease glutamatergic transmission in response to repeated bursts of endogenous glutamate release at this synapse. This novel finding is intriguing, given the substantial evidence for the presynaptic localization of mGlu 7 on SC terminals directly within the synaptic cleft (Shigemoto et al., 1996) . Despite this localization, the functional significance of this population of mGlu 7 in the regulation of glutamatergic transmission is unclear, and additional studies will be necessary to determine whether there are specific conditions or firing patterns necessary for synaptic activation of mGlu 7 .
Both electron microscopy and functional studies indicate that, in addition to its localization at glutamatergic terminals, mGlu 7 is located presynaptically on a variety of GABAergic interneuron terminals within the SC-CA1 region of the hippocampus where it can decrease GABAergic transmission onto CA1 pyramidal cells in response to agonist (Summa et al., 2013) . We again sought to determine whether we could observe mGlu 7 activation in response to endogenous glutamate release using the same stimulation paradigms used to study glutamatergic transmission. We observed no activation of mGlu 7 under lowfrequency stimulation; however, a consistent and significant activation of mGlu 7 was observed only using a 100 Hz stimulation paradigm. Thus, under periods of repeated, high-frequency firing of glutamatergic afferents, sufficient concentrations of glu- Working model of the mechanism by which mGlu 7 mediates induction of LTP at SC-CA1 synapses. mGlu 7 is a low-affinity mGlu receptor that is expressed presynaptically on both glutamatergic projections from CA3 and on interneurons in area CA1. Despite its localization directly within the synaptic cleft, it is only activated on GABAergic interneurons under strong synaptic activity when concentrations of glutamate are high. HFS induces robust glutamate release, which is sufficient to activate mGlu 7 located presynaptically on GABAergic interneurons. This activation induces an inhibition of GABA release and a disinhibition of the circuit, thus facilitating LTP induction. Further investigation will be necessary to determine how and when mGlu 7 becomes active on glutamatergic terminals and what the consequences of this activation are on transmission.
animals, and systemic administration of a different, structurally distinct mGlu 7 NAM, MMPIP, to wild-type mice results in deficits in object recognition and object localization tasks, which are models of nonspatial and spatial memory, respectively (Hikichi et al., 2010) . All of these data point toward a role for mGlu 7 in modulating learning in memory associated with the hippocampus.
Together, our results indicate that mGlu 7 does not act as a traditional autoreceptor in hippocampal area CA1 but instead functions under intense synaptic firing as a heteroceptor to decrease GABAergic transmission. We also provide the first evidence for a direct role of mGlu 7 in mediating induction of LTP at SC-CA1 synapses using a common induction paradigm. Additionally, we have shown that mGlu 7 's role as a frequencydependent presynaptic heteroeceptor located on GABAergic interneurons is critical for this mechanism. It will be important in future studies to determine the precise role of mGlu 7 in hippocampal-based learning and memory tasks as well as to investigate whether mGlu 7 also plays a role in induction of LTP using burst stimulation paradigms. It will also be important to determine whether mGlu 7 's role in synaptic plasticity is restricted to SC-CA1 synapses or whether it functions more broadly as a global regulator of plasticity in other circuits throughout the brain. One recent study found deficits in lateral amygdala LTP when mGlu 7 was blocked using a newly described orthosteric antagonist, XAP044 (Gee et al., 2014) , suggesting that this role for mGlu 7 could be observed in other brain regions. Finally, these data also indicate that compounds that agonize or potentiate mGlu 7 function could be efficacious in disease states where hippocampal LTP is deficient.
